CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial IVUS Guidance for Coronary Revascularization: When to Start, When to Stop? International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk What Is the Optimal Revascularization Strategy for Left Main Coronary Stenosis? ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison: JACC State-of-the-Art Review

Original Research2019 Oct 21;40(40):3345-3352.

JOURNAL:Eur Heart J. Article Link

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial

Morrow DA, Velazquez EJ, DeVore AD et al. Keywords: acute heart failure; biomarkers; troponin

FULL TEXT PDF